Edition:
India

Jubilant Life Sciences Ltd (JULS.BO)

JULS.BO on Bombay Stock Exchange

781.80INR
24 Mar 2017
Change (% chg)

Rs-7.50 (-0.95%)
Prev Close
Rs789.30
Open
Rs790.00
Day's High
Rs796.00
Day's Low
Rs778.05
Volume
44,584
Avg. Vol
129,569
52-wk High
Rs829.95
52-wk Low
Rs294.20

Select another date:

Tue, Mar 21 2017

BRIEF-Jubilant Life Sciences arm Jubilant Pharma to explore buying specialty pharma business in U.S.

* Board of Jubilant Pharma has approved to negotiate a potential acquisition of a specialty pharma business in U.S. Source text: http://bit.ly/2nMv0o8 Further company coverage:

BRIEF-Jubilant Life Sciences issues commercial papers worth 400 mln rupees

* Says issuance of commercial papers of Rs. 40 crore Source text: http://bit.ly/2ltyCtM Further company coverage:

BRIEF-Jubilant Life Sciences' generic drug for fungal infection gets FDA nod

* Says Jubilant Life Sciences receives ANDA approval for itraconazole capsules

BRIEF-Jubilant Life Sciences approves purchase of 1.87 bln rupees worth preference shares of Jubilant Biosys

* Approved acquisition of optionally convertible redeemable preference shares of Jubilant Biosys aggregating to 1.87 billion rupees Source text: http://bit.ly/2kIuKId Further company coverage:

BRIEF-Jubilant Life Sciences issues NCDs worth 4.95 bln rupees

* Jubilant Life Sciences issues NCDs worth 4.95 billion rupees Source text: (http://bit.ly/2jwwMtL) Further company coverage:

BRIEF-Jubilant Life Sciences seeks members' nod for issue of NCDs worth up to 10 bln rupees

* Seeks members' nod for issue of non-convertible debentures worth up to 10 billion rupees Source text: http://bit.ly/2gmAC4b Further company coverage:

BRIEF-Indo Borax & Chemicals restarts production activity from Pithampur plant

* Restarted production activity from Pithampur plant from November 10, 2016. Source text: http://bit.ly/2fHAImr Further company coverage:

BRIEF-Jubilant Life Sciences announces commercial paper issue of 500 mln rupees

* Says issuance of commercial papers of 500 million rupees Source text: http://bit.ly/2fCg3lh Further company coverage:

BRIEF-Jubilant Life Sciences gets FDA nod for generic version of Crestor drug

* Says Jubilant Life Sciences receives ANDA approval for rosuvastatin calcium tablets Source text: http://bit.ly/2f8kxjy Further company coverage: (Bengaluru newsroom)

BRIEF-Jubilant Life Sciences Sept-qtr consol profit up about 15 pct

* Net profit in sept quarter last year was 1.26 billion rupees as per Ind-AS; net sales was 14.74 billion rupees Source text (http://bit.ly/2eymiYy) Further company coverage: (Bengaluru newsroom)

Select another date:

More From Around the Web